Search - tctmd.com

Displaying 21 - 40 of 420

Sort: Relevancy | Date

Presentation TCT 2024

Lesion-Specific Drug Eluting Stents: Are They Still Needed?

Presenter: Joanna Wykrzykowska

October 30, 2024

Presentation TCT 2024

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

Presenter: Han Chen

October 29, 2024

Presentation TCT 2024

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

Presenter: Kazuki Aihara

October 29, 2024

Presentation TCT 2024

TCT 433: Five-Year Clinical Results of Patients Treated With Angiolite® Drug Eluting Stents: Real Life Registry (Epic02 - Rango Study)

Presenter: Armando Perez de Prado

October 28, 2024

Presentation TCT 2024

TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial

Presenter: Juan F. Iglesias

October 28, 2024

Presentation TCT 2024

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

Presenter: Hesham Refaat

October 28, 2024

Presentation TCT 2024

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

Presenter: Jeremy Levett

October 28, 2024

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

Presentation TCT 2023

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

Presenter: Rayyan Hemetsberger

October 25, 2023

Presentation TCT 2023

TCT 255: Sex differences in procedural characteristics and clinical outcomes among patients undergoing bifurcation PCI using second-generation drug-eluting stents

Presenter: Hyun Jin Ahn

October 25, 2023

Presentation TCT 2023

TCT 424: In Vitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting from Intravascular Lithotripsy

Presenter: Doosup Shin

October 25, 2023

Presentation TCT 2023

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

Presenter: Eline Ploumen

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

Presentation TCT 2023

TCT 565: Drug-Coated Versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated With Provisional Stenting Using Drug-Eluting Stents: Randomized Study

Presenter: MEFTAH Abdelouahed

October 25, 2023

Presentation TCT 2023

TCT 1007: What lesion would you do first/what is the culprit artery ? - Is Drug Eluting Balloon, good as stents?

Presenter: Thisara Samarawickrama

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

TCT 229: Effect of delayed hospitalization on patients with non-ST-segment elevation myocardial infarction and complex lesions undergoing successful new-generation drug-eluting stents implantation

Presenter: Yong Hoon Kim

October 24, 2023

Presentation TCT 2023

TCT 351: Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion, 10-year Extended Follow-up Results

Presenter: Seung-Whan Lee

October 24, 2023

Presentation TCT 2023

TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry)

Presenter: Wojciech Wanha

October 24, 2023

Advertisement

Lesion-Specific Drug Eluting Stents: Are They Still Needed?

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

TCT 433: Five-Year Clinical Results of Patients Treated With Angiolite® Drug Eluting Stents: Real Life Registry (Epic02 - Rango Study)

TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

TCT 255: Sex differences in procedural characteristics and clinical outcomes among patients undergoing bifurcation PCI using second-generation drug-eluting stents

TCT 424: In Vitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting from Intravascular Lithotripsy

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Comparing DCBs in De Novo CAD: Drugs, Design Matter

TCT 565: Drug-Coated Versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated With Provisional Stenting Using Drug-Eluting Stents: Randomized Study

TCT 1007: What lesion would you do first/what is the culprit artery ? - Is Drug Eluting Balloon, good as stents?

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

TCT 229: Effect of delayed hospitalization on patients with non-ST-segment elevation myocardial infarction and complex lesions undergoing successful new-generation drug-eluting stents implantation

TCT 351: Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion, 10-year Extended Follow-up Results

TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content